Flputnam Investment Management Co. Acquires Shares of 160,903 Phreesia, Inc. $PHR

Flputnam Investment Management Co. acquired a new position in Phreesia, Inc. (NYSE:PHR) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 160,903 shares of the company’s stock, valued at approximately $1,656,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Bank of New York Mellon Corp acquired a new position in shares of Phreesia in the second quarter worth $1,901,000. Focus Partners Advisor Solutions LLC bought a new stake in Phreesia in the second quarter worth approximately $169,000. State of Wyoming acquired a new position in shares of Phreesia during the 2nd quarter worth $229,000. GSA Capital Partners LLP bought a new position in shares of Phreesia during the 2nd quarter valued at $245,000. Finally, NewEdge Advisors LLC raised its holdings in shares of Phreesia by 2,395,000.0% during the 1st quarter. NewEdge Advisors LLC now owns 23,951 shares of the company’s stock valued at $201,000 after purchasing an additional 23,950 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on PHR shares. Citigroup reiterated a “market perform” rating on shares of Phreesia in a report on Friday, May 29th. Wall Street Zen upgraded Phreesia from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Barclays reaffirmed an “equal weight” rating and set a $10.00 target price (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Wells Fargo & Company reiterated an “equal weight” rating and set a $9.00 price target (down from $15.00) on shares of Phreesia in a report on Wednesday, May 20th. Finally, Canaccord Genuity Group dropped their price target on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $16.65.

Phreesia Trading Down 6.0%

Shares of Phreesia stock opened at $11.54 on Tuesday. Phreesia, Inc. has a 52-week low of $7.77 and a 52-week high of $32.76. The firm has a market capitalization of $713.31 million, a PE ratio of 76.93 and a beta of 0.85. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The company’s fifty day moving average price is $10.56 and its two-hundred day moving average price is $10.56.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The business had revenue of $130.94 million for the quarter, compared to analyst estimates of $130.08 million. During the same period in the previous year, the business earned ($0.07) EPS. The firm’s revenue was up 12.9% on a year-over-year basis. On average, analysts expect that Phreesia, Inc. will post 0.39 EPS for the current year.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.